Clopidogrel benzene sulfonate

Comparison of the antiplatelet effect of clopidogrel benzene sulfonate and clopidogrel hydrogen sulfate in stable coronary heart disease

S. H. Wang, Li, X., Hou, F. L., Tian, Y. J., Liu, Y. H., Zheng, S. L., Wang, S. H., Li, X., Hou, F. L., Tian, Y. J., Liu, Y. H., Zheng, S. L., Wang, S. H., Li, X., Hou, F. L., Tian, Y. J., Liu, Y. H., and Zheng, S. L., Comparison of the antiplatelet effect of clopidogrel benzene sulfonate and clopidogrel hydrogen sulfate in stable coronary heart disease, vol. 15, p. -, 2016.

Clopidogrel hydrogen sulfate (CHS) is a thienopyridine, which can be used to prevent cardiovascular complications alone or in combination with acetyl salicylic acid as an important antiplatelet agent. Clopidogrel benzene sulfonate (CB) is a special clopidogrel salt that can be used as a conventional drug for antiplatelet effects, but the mechanism is still unknown. This study aimed to compare the antiplatelet effects of CHS and CB in stable coronary artery disease patients.

Subscribe to Clopidogrel benzene sulfonate